Clinical Investigative Site # 6228 — Greenville, South Carolina

Clinical Investigative Site # 6228 is a clinical research site located in Greenville, South Carolina, United States 29615.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Clinical Investigative Site # 6228 has participated in 1 clinical trials.

Therapeutic areas: Asthma.

Sponsors: Idorsia Pharmaceuticals Ltd..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Clinical Investigative Site # 6228?

Clinical Investigative Site # 6228 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Clinical Investigative Site # 6228 conducted?

Clinical Investigative Site # 6228 has 1 clinical trials on record. Their work covers Asthma.

Is Clinical Investigative Site # 6228 accredited by Crixeo Health?

Clinical Investigative Site # 6228 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Clinical Investigative Site # 6228?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.